Abstract:Background: Previous study reveals that, exogenous bone marrow mesenchymal stem cells (MSCs) may settle down in kidney and differentiate into renal cells, as well as participate in the repair of injured renal tissues. However, the repairing pathway is unclear. Objective: To investigate the potential effect of exogenous MSCs transplantation on renal injury. Design, time and setting: An in vivo trial of cytology was performed in the Urinary Surgery Institute of Nanchang University (Nanchang, Jiangxi, China) from March to September in 2007. Materials: Fifty-six SD rats of clean grade were recruited. Eight male rats of them were used to prepare MSCs, while other 48 female rats were divided into three groups at random, namely cell transplantation group, model control group and sham group. Each group contained 16 rats. Fluorochrome DAPI was a product of Biotium Inc. Ricinus communis agglutinin was produced by Vector Laboratories. BrdU was offered by Sigma. Methods: Bone marrow-derived MSCs were collected from male SD rats, then isolated by Percoll density gradient centrifugation and labeled with DAPI at a density of 1.5 × 1010/L. Renal injury models induced by ischemia and reperfusion were created in cell transplantation group and model control, while renal vessels were not ligated in the sham group. SD rats were subjected to clamping renal pedicles for 45 minutes. DAPI-labeled MSCs or 1 mL saline were transplanted into the rats by inferior vena cava in cell transplantation group or model control group and sham group. All animals received daily injection of BrdU, then blood and renal tissues were sampled. Main outcome measures: Immunohistochemical methods and fluorescence microscope were performed to identify transplanted MSCs and BrdU in renal tissues. To confirm if the MSCs may differentiate into renal tubular cells, ricinus communis agglutinin that binds specifically to the luminal surface of tubules was used. Biochemistry methods were used to detect the levels of creatinine and blood urea nitrogen in serum. Results: At day 3 after transplantation, the DAPI-positive cells were few, but obviously increased at day 4 (P < 0.05). Most of DAPI-labeled cells could express ricinus communis agglutinin-positive cells simultaneously and were mainly distributed in the renal tubule. There were few positive cells in renal cortex and kidney inner medullary, even absent in renal glomerulus. In sham group, the renal tissue cells proliferated slowly, and BrdU-positive cells were remarkably lower than that in model control group at day 4 (P < 0.05); BrdU-positive cells were distributed identically with DAPI-positive cells in the cell transplantation and model control groups at days 2, 3 and 4, but the BrdU-positive cells in transplantation group were much more than that of the control group (P < 0.05) Compared with the model control group, the serum level of blood urea nitrogen in cell transplantation group was significantly decreased at days 1 and 2 (P < 0.05), and the serum levels of creatinine were significantly lower at days 1, 2 and 3 (P < 0.05). Conclusion: Exogenous MSCs can migrate and repopulate in the ischemically injured kidney, differentiate into renal tubular cells and promote cells proliferation to repair renal injury. MSCs have depressant effect on increasing degrees of blood urea nitrogen and creatinine at early stage, this protective effect has no association with location and differentiation of MSCs.

Bone marrow mesenchymal stem cells protect against renal ischemia-reperfusion injury through immune regulatory mechanism

Bone marrow mesenchymal stem cells protect against renal ischemia reperfusion injury through paracrine mechanism

Curative Effect of Different Transplantation Ways of Bone Marrow Mesenchymal Stem Cells on Renal Ischemia Reperfusion Injury

Bone Marrow Mesenchymal Stem Cells Ameliorated Kidney Fibrosis by Attenuating TLR4/NF-κB in Diabetic Rats.

Mobilization of autologous bone marrow stem cells is involved in cell apoptosis and proliferation following renal ischemia-reperfusion injuries

Bone Marrow Mesenchymal Stem Cells Promote Cells Proliferation in Renal Tissues with Ischemia-Reperfusion Injury

Bone marrow mesenchymal stem cell-derived exosome protects kidney against ischemia reperfusion injury in rats

Bone Marrow Mesenchymal Stem Cells Repair Spinal Cord Ischemia/reperfusion Injury by Promoting Axonal Growth and Anti-Autophagy.

Protective Effect Of Bone Marrow Mesenchymal Stem Cells Modified With Klotho On Renal Ischemia-Reperfusion Injury

Repair of acute ischemia-reperfusion renal injury by bone marrow mesenchymal stem cells transplantation in rats

Mesenchymal Stem Cells in Renal Ischemia-Reperfusion Injury: Biological and Therapeutic Perspectives

Improvement of Bone Marrow Mesenchymal Stem Cells on Kidney Function and Level of Oxidative Stress after Renal Ischemia-Reperfusion Injury

Anti-apoptosis Role of Bone Marrow Mesenchymal Stem Cells in the Early Phase of Acute Renal Ischemia-Reperfusion Injury

Bone marrow mesenchymal stem cells transplantation for the repair of renal injury

Mechanism of mouse bone marrow mesenchymal stem cells for alleviating kidney ischemic-reperfusion injury via glucose metabolism

Exosomes Derived from Mesenchymal Stem Cells Ameliorate Renal Ischemic-Reperfusion Injury Through Inhibiting Inflammation and Cell Apoptosis

Mesenchymal stem cells pretreatment protects against liver ischemia-reperfusion injury

Effect of Tramsplanted Bone Marrow Stem Cells on Renal Tubular Epithelial Cells after Acut Renal Ischemic Injury in Rats

Therapeutic Effects of Stem Cells from Different Source on Renal Ischemia- Reperfusion Injury: A Systematic Review and Network Meta-analysis of Animal Studies

The rehabilitation effect of the bone marrow mesenchymal stem cells for hepatic ischemia-reperfusion injury

Effect of bone marrow mesenchymal stem cells on the recovery of renal ischemia-reperfusion injury in different strain mice